Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Beyond extracellular vesicles: hybrid membrane nanovesicles as emerging advanced tools for biomedical applications
M Sun, J Yang, Y Fan, Y Zhang, J Sun, M Hu… - Advanced …, 2023 - Wiley Online Library
Extracellular vesicles (EVs), involved in essential physiological and pathological processes
of the organism, have emerged as powerful tools for disease treatment owing to their unique …
of the organism, have emerged as powerful tools for disease treatment owing to their unique …
Recent progress in carrier‐free nanomedicine for tumor phototherapy
YT Zhong, Y Cen, L Xu, SY Li… - Advanced Healthcare …, 2023 - Wiley Online Library
Safe and effective strategies are urgently needed to fight against the life‐threatening
diseases of various cancers. However, traditional therapeutic modalities, such as …
diseases of various cancers. However, traditional therapeutic modalities, such as …
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Y Peng, S Liang, QF Meng, D Liu, K Ma… - Advanced …, 2024 - Wiley Online Library
Immunotherapy represents a revolutionary paradigm in cancer management, showcasing its
potential to impede tumor metastasis and recurrence. Nonetheless, challenges including …
potential to impede tumor metastasis and recurrence. Nonetheless, challenges including …
Radiation‐induced immunogenic cell death for cancer radioimmunotherapy
In cancer treatment, traditional radiotherapy (RT) is routinely conducted in local tumors and
limited by radioresistance, while recently emerged immunotherapy is confronted with low …
limited by radioresistance, while recently emerged immunotherapy is confronted with low …
Recent progress on photodynamic therapy and photothermal therapy
Noninvasive treatments for terminal cancer patients constitute a new trend in tumor
treatment. Therefore, phototherapy, including photodynamic therapy (PDT) and …
treatment. Therefore, phototherapy, including photodynamic therapy (PDT) and …
Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective
Z Pei, L Li, N Yang, S Sun, N Jiang, L Cheng - Coordination Chemistry …, 2024 - Elsevier
Metal, as an active participant in life activities, has always been at the forefront of research.
Recent studies have revealed the crucial role of metal ions in activating the anti-tumor …
Recent studies have revealed the crucial role of metal ions in activating the anti-tumor …
Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy
L Yang, Y Wang, Y Song, Z Li, L Lei, H Li, B He… - Journal of Controlled …, 2024 - Elsevier
Activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING)
pathway is an effective way to initiate an immune response against tumors, and the research …
pathway is an effective way to initiate an immune response against tumors, and the research …
Recent advances in Prussian blue-based photothermal therapy in cancer treatment
K Tang, X Li, Y Hu, X Zhang, N Lu, Q Fang… - Biomaterials …, 2023 - pubs.rsc.org
Malignant tumours are a serious threat to human health. Traditional chemotherapy has
achieved breakthrough improvements but also has significant detrimental effects, such as …
achieved breakthrough improvements but also has significant detrimental effects, such as …
Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect
B Chen, R Huang, W Zeng, W Wang, Y Min - Biomaterials, 2024 - Elsevier
The immunosuppressive tumor microenvironment (TME) greatly limits the actual outcome of
immunotherapy. Therefore, it is urgent to develop appropriate strategies to reshape the TME …
immunotherapy. Therefore, it is urgent to develop appropriate strategies to reshape the TME …
Drug delivery methods for cancer immunotherapy
Despite the fact that numerous immunotherapy-based drugs have been approved by the
FDA for the treatment of primary and metastatic tumors, only a small proportion of the …
FDA for the treatment of primary and metastatic tumors, only a small proportion of the …